By earn 
BUY BATA 1372 STOPLOSS 1352 TARGET 1400 BUY BATA 1372 STOPLOSS 1352 TARGET 1400
Please follow and like us:
Related posts:
- Vedanta The board approved raising up to Rs 8,500 crore via equity and approved the investment in Vedanta Copper International for setting up a copper rod plant in Saudi Arabia Vedanta The board approved raising up to Rs 8,500 crore via equity and approved the investment in Vedanta Copper International for setting up a copper rod plant in Saudi Arabia
- Power – State Specific Reforms next given Power deficit situation ? Rajasthan targets 90 GW by 2030 Huge Transmission & Power growth ahead just in 1 state Expect similar play across Solar & Wind States Kay Cee Energy – Watchout this specific company for Transmission Projects in Rajasthan Power – State Specific Reforms next given Power deficit situation ? Rajasthan targets 90 GW by 2030 Huge Transmission & Power growth ahead just in 1 state Expect similar play across Solar & Wind States Kay Cee Energy – Watchout this specific company for Transmission Projects in Rajasthan
- UK Economic Event • Claimant Count Change (Sep): Actual 27.9K Forecast 20.2K Previous 0.3K • Employment Change 3M/3M (MoM) (Aug): Actual 373K Forecast 250K Previous 265K • Unemployment Rate (Aug): Actual 4.0% Forecast 4.1% Previous 4.1% • Average Earnings ex Bonus (Aug): Actual 4.9% Forecast 4.9% Previous 5.1% #FinancialNews #Financial MarketTrends  https://earnfree.in/latest UK Economic Event • Claimant Count Change (Sep): Actual 27.9K Forecast 20.2K Previous 0.3K • Employment Change 3M/3M (MoM) (Aug): Actual 373K Forecast 250K Previous 265K • Unemployment Rate (Aug): Actual 4.0% Forecast 4.1% Previous 4.1% • Average Earnings ex Bonus (Aug): Actual 4.9% Forecast 4.9% Previous 5.1% #FinancialNews #Financial MarketTrends  https://ift.tt/yXeuJSs
- *MASSIVE SETBACK FOR ZYDUS LIFE* Exelixis Wins Patent Ruling Over MSN Labs’ Cabometyx Copies MSN WILL NOT BE ABLE TO LAUNCH DRUG ZYDUS WAS MSN PARTNER, BIG SETBACK *MASSIVE SETBACK FOR ZYDUS LIFE* Exelixis Wins Patent Ruling Over MSN Labs’ Cabometyx Copies MSN WILL NOT BE ABLE TO LAUNCH DRUG ZYDUS WAS MSN PARTNER, BIG SETBACK